These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 9831349)
1. X-inactivation pattern in the liver of a manifesting female with ornithine transcarbamylase (OTC) deficiency. Yorifuji T; Muroi J; Uematsu A; Tanaka K; Kiwaki K; Endo F; Matsuda I; Nagasaka H; Furusho K Clin Genet; 1998 Oct; 54(4):349-53. PubMed ID: 9831349 [TBL] [Abstract][Full Text] [Related]
2. Familial lethal inheritance of a mutated paternal gene in females causing X-linked ornithine transcarbamylase (OTC) deficiency. Komaki S; Matsuura T; Oyanagi K; Hoshide R; Kiwaki K; Endo F; Shimadzu M; Matsuda I Am J Med Genet; 1997 Mar; 69(2):177-81. PubMed ID: 9056557 [TBL] [Abstract][Full Text] [Related]
3. Variable X-chromosome inactivation and enlargement of pericentral glutamine synthetase zones in the liver of heterozygous females with OTC deficiency. Musalkova D; Sticova E; Reboun M; Sokolova J; Krijt J; Honzikova J; Gurka J; Neroldova M; Honzik T; Zeman J; Jirsa M; Dvorakova L; Hrebicek M Virchows Arch; 2018 Jun; 472(6):1029-1039. PubMed ID: 29623395 [TBL] [Abstract][Full Text] [Related]
4. Complete deletion of ornithine transcarbamylase gene confirmed by CGH array of X chromosome. Arranz JA; Madrigal I; Riudor E; Armengol L; Milà M J Inherit Metab Dis; 2007 Oct; 30(5):813. PubMed ID: 17570074 [TBL] [Abstract][Full Text] [Related]
5. Asymptomatic and late-onset ornithine transcarbamylase deficiency caused by a A208T mutation: clinical, biochemical and DNA analyses in a four-generation family. Ausems MG; Bakker E; Berger R; Duran M; van Diggelen OP; Keulemans JL; de Valk HW; Kneppers AL; Dorland L; Eskes PF; Beemer FA; Poll-The BT; Smeitink JA Am J Med Genet; 1997 Jan; 68(2):236-9. PubMed ID: 9028466 [TBL] [Abstract][Full Text] [Related]
7. Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype. McCullough BA; Yudkoff M; Batshaw ML; Wilson JM; Raper SE; Tuchman M Am J Med Genet; 2000 Aug; 93(4):313-9. PubMed ID: 10946359 [TBL] [Abstract][Full Text] [Related]
8. Gene deletion and restriction fragment length polymorphisms at the human ornithine transcarbamylase locus. Rozen R; Fox J; Fenton WA; Horwich AL; Rosenberg LE Nature; 1985 Feb 28-Mar 6; 313(6005):815-7. PubMed ID: 2983225 [TBL] [Abstract][Full Text] [Related]
9. New mutation and prenatal diagnosis in ornithine transcarbamylase deficiency. Nussbaum RL; Boggs BA; Beaudet AL; Doyle S; Potter JL; O'Brien WE Am J Hum Genet; 1986 Feb; 38(2):149-58. PubMed ID: 3004207 [TBL] [Abstract][Full Text] [Related]
10. OTC deficiency in females: Phenotype-genotype correlation based on a 130-family cohort. Gobin-Limballe S; Ottolenghi C; Reyal F; Arnoux JB; Magen M; Simon M; Brassier A; Jabot-Hanin F; Lonlay P; Pontoizeau C; Guirat M; Rio M; Gesny R; Gigarel N; Royer G; Steffann J; Munnich A; Bonnefont JP J Inherit Metab Dis; 2021 Sep; 44(5):1235-1247. PubMed ID: 34014569 [TBL] [Abstract][Full Text] [Related]
11. The molecular basis of ornithine transcarbamylase deficiency. Tuchman M; McCullough BA; Yudkoff M Eur J Pediatr; 2000 Dec; 159 Suppl 3():S196-8. PubMed ID: 11216899 [TBL] [Abstract][Full Text] [Related]
12. Recapitulation of Skewed X-Inactivation in Female Ornithine Transcarbamylase-Deficient Primary Human Hepatocytes in the FRG Mouse: A Novel System for Developing Epigenetic Therapies. Cunningham SC; van Dijk EB; Zhu E; Sugden M; Mandwie M; Siew S; Devanapalli B; Tolun AA; Klein A; Wilson L; Aryamanesh N; Gissen P; Baruteau J; Bhattacharya K; Alexander IE Hum Gene Ther; 2023 Sep; 34(17-18):917-926. PubMed ID: 37350098 [TBL] [Abstract][Full Text] [Related]
13. Ornithine transcarbamylase deficiency. Yeh SJ; Hou WL; Tsai WS; Wu TJ; Tuchman M; Wang TR J Formos Med Assoc; 1997 Jan; 96(1):43-5. PubMed ID: 9033181 [TBL] [Abstract][Full Text] [Related]
15. The phenotype of ostensibly healthy women who are carriers for ornithine transcarbamylase deficiency. Maestri NE; Lord C; Glynn M; Bale A; Brusilow SW Medicine (Baltimore); 1998 Nov; 77(6):389-97. PubMed ID: 9854602 [TBL] [Abstract][Full Text] [Related]
16. Impact of enzyme activity assay on indication in liver transplantation for ornithine transcarbamylase deficiency. Wakiya T; Sanada Y; Urahashi T; Ihara Y; Yamada N; Okada N; Ushijima K; Otomo S; Sakamoto K; Murayama K; Takayanagi M; Hakamada K; Yasuda Y; Mizuta K Mol Genet Metab; 2012 Mar; 105(3):404-7. PubMed ID: 22264779 [TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes and the mutation spectrum of the OTC gene in patients with ornithine transcarbamylase deficiency. Choi JH; Lee BH; Kim JH; Kim GH; Kim YM; Cho J; Cheon CK; Ko JM; Lee JH; Yoo HW J Hum Genet; 2015 Sep; 60(9):501-7. PubMed ID: 25994866 [TBL] [Abstract][Full Text] [Related]
18. DNA analysis for ornithine transcarbamylase deficiency. Rozen R; Fox JE; Hack AM; Fenton WA; Horwich AL; Rosenberg LE J Inherit Metab Dis; 1986; 9 Suppl 1():49-57. PubMed ID: 2878115 [TBL] [Abstract][Full Text] [Related]
19. Activity of the liver enzyme ornithine carbamoyltransferase (OTC) in blood: LC-MS/MS assay for non-invasive diagnosis of ornithine carbamoyltransferase deficiency. Krijt J; Sokolová J; Ješina P; Dvořáková L; Řeboun M; Brennerová K; Mistrík M; Zeman J; Honzík T; Kožich V Clin Chem Lab Med; 2017 Jul; 55(8):1168-1177. PubMed ID: 28107167 [TBL] [Abstract][Full Text] [Related]
20. Hyperammonemia in ornithine transcarbamylase-deficient recipients following living donor liver transplantation from heterozygous carrier donors. Rahayatri TH; Uchida H; Sasaki K; Shigeta T; Hirata Y; Kanazawa H; Mali V; Fukuda A; Sakamoto S; Kasahara M Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27891735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]